160 related articles for article (PubMed ID: 7548444)
1. Inhibitory effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on rat hepatocyte proliferation induced by 2/3 partial hepatectomy.
Bauman JW; Goldsworthy TL; Dunn CS; Fox TR
Cell Prolif; 1995 Aug; 28(8):437-51. PubMed ID: 7548444
[TBL] [Abstract][Full Text] [Related]
2. Gene expression and cell proliferation in rat liver after 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure.
Fox TR; Best LL; Goldsworthy SM; Mills JJ; Goldsworthy TL
Cancer Res; 1993 May; 53(10 Suppl):2265-71. PubMed ID: 8485713
[TBL] [Abstract][Full Text] [Related]
3. NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Apr; (521):4-232. PubMed ID: 16835633
[TBL] [Abstract][Full Text] [Related]
4. 2,3,7,8-Tetrachlorodibenzo-p-dioxin inhibits DNA synthesis in rat primary hepatocytes.
Hushka DR; Greenlee WF
Mutat Res; 1995 Dec; 333(1-2):89-99. PubMed ID: 8538640
[TBL] [Abstract][Full Text] [Related]
5. Roles of growth factors and of tumor necrosis factor-alpha on liver cell proliferation induced in rats by lead nitrate.
Shinozuka H; Kubo Y; Katyal SL; Coni P; Ledda-Columbano GM; Columbano A; Nakamura T
Lab Invest; 1994 Jul; 71(1):35-41. PubMed ID: 8041116
[TBL] [Abstract][Full Text] [Related]
6. Toxicology and carcinogenesis studies of a mixture of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (Cas No. 1746-01-6), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4), and 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) in female Harlan Sprague-Dawley rats (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Sep; (526):1-180. PubMed ID: 17342195
[TBL] [Abstract][Full Text] [Related]
7. Differential patterns of expression of three C/EBP isoforms, HNF-1, and HNF-4 after partial hepatectomy in rats.
Flodby P; Antonson P; Barlow C; Blanck A; Porsch-Hällström I; Xanthopoulos KG
Exp Cell Res; 1993 Sep; 208(1):248-56. PubMed ID: 8359219
[TBL] [Abstract][Full Text] [Related]
8. Persistence of TCDD-induced hepatic cell proliferation and growth of enzyme altered foci after chronic exposure followed by cessation of treatment in DEN initiated female rats.
Tritscher AM; Clark GC; Sewall C; Sills RC; Maronpot R; Lucier GW
Carcinogenesis; 1995 Nov; 16(11):2807-11. PubMed ID: 7586202
[TBL] [Abstract][Full Text] [Related]
9. Sustained aryl hydrocarbon receptor activity attenuates liver regeneration.
Mitchell KA; Lockhart CA; Huang G; Elferink CJ
Mol Pharmacol; 2006 Jul; 70(1):163-70. PubMed ID: 16636136
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of ornithine decarboxylase activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Potter CL; Sipes IG; Russell DH
Biochem Pharmacol; 1982 Nov; 31(21):3367-71. PubMed ID: 6184059
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of cell cycle progression by 2,3,7,8-tetrachlorodibenzo-p-dioxin eliciting ovulatory blockade in gonadotropin-primed immature rats.
Jung NK; Park JY; Park JH; Kim SY; Park JK; Chang WK; Lee HC; Kim SW; Chun SY
Endocr J; 2010; 57(10):863-71. PubMed ID: 20724799
[TBL] [Abstract][Full Text] [Related]
12. Toxicology and carcinogenesis studies of a binary mixture of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) and 2,3',4,4',5-pentachlorobiphenyl (PCB 118) (Cas No. 31508-00-6) in female Harlan Sprague-Dawley rats (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Nov; (531):1-218. PubMed ID: 17342196
[TBL] [Abstract][Full Text] [Related]
13. Nonresponsiveness to 2,3,7,8-tetrachlorodibenzo-p-dioxin of transforming growth factor beta1 and CYP 1A1 gene expression in rat liver fat-storing cells.
Riebniger D; Schrenk D
Toxicol Appl Pharmacol; 1998 Sep; 152(1):251-60. PubMed ID: 9772220
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the promotion of altered hepatic foci by 2,3,7,8-tetrachlorodibenzo-p-dioxin in the female rat.
Dragan YP; Xu XH; Goldsworthy TL; Campbell HA; Maronpot RR; Pitot HC
Carcinogenesis; 1992 Aug; 13(8):1389-95. PubMed ID: 1354083
[TBL] [Abstract][Full Text] [Related]
15. Consequences of TCDD treatment on intra-hepatic lymphocytes during liver regeneration.
Horras CJ; Lamb CL; King AL; Hanley JR; Mitchell KA
J Immunotoxicol; 2012; 9(4):359-67. PubMed ID: 22530936
[TBL] [Abstract][Full Text] [Related]
16. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
[TBL] [Abstract][Full Text] [Related]
17. Quantitative evaluation of the promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin of hepatocarcinogenesis from diethylnitrosamine.
Pitot HC; Goldsworthy T; Campbell HA; Poland A
Cancer Res; 1980 Oct; 40(10):3616-20. PubMed ID: 6108157
[TBL] [Abstract][Full Text] [Related]
18. Ovarian hormones enhance 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated increases in cell proliferation and preneoplastic foci in a two-stage model for rat hepatocarcinogenesis.
Lucier GW; Tritscher A; Goldsworthy T; Foley J; Clark G; Goldstein J; Maronpot R
Cancer Res; 1991 Mar; 51(5):1391-7. PubMed ID: 1671757
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of gap junctional intercellular communication by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in rat hepatocytes.
Baker TK; Kwiatkowski AP; Madhukar BV; Klaunig JE
Carcinogenesis; 1995 Oct; 16(10):2321-6. PubMed ID: 7586129
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte proliferation induced in rats by lead nitrate is suppressed by several tumor necrosis factor alpha inhibitors.
Kubo Y; Yasunaga M; Masuhara M; Terai S; Nakamura T; Okita K
Hepatology; 1996 Jan; 23(1):104-14. PubMed ID: 8550029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
